Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-3500Fax+1 314-230-1119
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1977 - 1980
- University of Maryland School of MedicineClass of 1977
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Lipid Research Clinics Coronary Primary Prevention Trial (CPPT) Start of enrollment: 1973 Jun 01
- Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia Start of enrollment: 2021 Jan 27
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins.Jing Cao, Leslie Donato, Joe M El-Khoury, Anne Goldberg, Jeffrey W Meeusen
The Journal of Applied Laboratory Medicine. 2024-09-03 - NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents.Anne Carol Goldberg, Daniel Soffer, Christe Ballantyne, Martha Gulati, Michael Shapiro
American Journal of Preventive Cardiology. 2024-03-01 - Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials.P Barton Duell, Maciej Banach, Alberico L Catapano, Ulrich Laufs, G B John Mancini
Journal of Clinical Lipidology. 2024-01-11
Lectures
- Cholesterol-Carrying Lipoproteins and Cardiovascular Risk: New Guidelines and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardiovascular Risk: The CLEAR Wisdom Trial2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- LDL-C and Beyond: Harnessing the Power of Novel Therapeutic Targets and Big Data to Improve Dyslipidemia Care2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Press Mentions
- ADLM Publishes Guidance on Lipid Testing for Cardiovascular DiseaseSeptember 3rd, 2024
- Early Results Show Promise of an Oral PCSK9 InhibitorNovember 15th, 2021
- Pooled Analyses Show NILEMDO®▼ Significantly Lowers Cholesterol in Different Subgroups in Phase 3 Data Presented at AHA 2020November 16th, 2020
- Join now to see all
Professional Memberships
- Member
- Fellow
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: